...
首页> 外文期刊>Journal of Medicinal Chemistry >Structure-Activity Relationship and Mechanism of Action Studies of Manzamine Analogues for the Control of Neuroinflammation and Cerebral Infections
【24h】

Structure-Activity Relationship and Mechanism of Action Studies of Manzamine Analogues for the Control of Neuroinflammation and Cerebral Infections

机译:结构-活性关系和控制神经炎症和脑感染的甘露糖胺类似物的作用机理研究

获取原文
获取原文并翻译 | 示例

摘要

Structure-activity relationship studies were carried out by chemical modification of manzamine A (1), 8-hydroxymanzamine A (2), manzamine F (14), and ircinal isolated from the sponge Acanthostrongylophora. The derived analogues were evaluated for antimalarial, antimicrobial, and antineuroinflammatory activities. Several modified products exhibited potent and improved in vitro antineuroinflammatory, antimicrobial, and antimalarial activity. 1 showed improved activity against malaria compared to chloroquine in both multi- and single-dose in vivo experiments. The significant antimalarial potential was revealed by a 100% cure rate of malaria in mice with one administration of 100 mg/kg of 1. The potent antineuroinflammatory activity of the manzamines will provide great benefit for the prevention and treatment of cerebral infections (e.g., Cryptococcus and Plasmodium). In addition, 1 was shown to permeate across the blood-brain barrier (BBB) in an in vitro model using aMDR-MDCKmonolayer. Docking studies support that 2 binds to the ATP-noncompetitive pocket of glycogen synthesis kinase-3β (GSK-3β), which is a putative target of manzamines. On the basis of the results presented here, it will be possible to initiate rational drug design efforts around this natural product scaffold for the treatment of several different diseases.
机译:通过化学修饰甘露糖胺A(1),8-羟基甘露糖胺A(2),甘露糖胺F(14)和从海绵Acanthostrongylophora中分离出的鸟皮进行结构-活性关系研究。评估了衍生的类似物的抗疟疾,抗微生物和抗神经炎活性。几种修饰的产品表现出有效的体外抗炎,抗微生物和抗疟疾活性。图1显示在多剂量和单剂量体内实验中,与氯喹相比,抗疟疾活性提高。一次给予100 mg / kg的1的小鼠,疟疾的治愈率达到100%,显示出显着的抗疟疾潜力。甘露糖胺的强力抗神经炎活性将为预防和治疗脑部感染(例如隐球菌)带来巨大益处和疟原虫)。此外,在使用aMDR-MDCK单层的体外模型中,有1个渗透穿过血脑屏障(BBB)。对接研究支持2结合糖原合成激酶3β(GSK-3β)的ATP非竞争性口袋,而糖原合成激酶3β是拟定的山z胺靶标。根据此处给出的结果,将有可能围绕这种天然产物支架开展合理的药物设计工作,以治疗几种不同的疾病。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号